Clincosm LogoSign in Get a demo

gastroesophageal junction adenocarcinoma

Showing 76 - 99 of 99
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, NSCLC Trial in Worldwide (Ramucirumab, MEDI4736)

Completed
  • Gastric Cancer
  • +3 more
  • Santa Monica, California
  • +27 more
Jan 18, 2021

Advanced Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Boston, New York, Nashville

Completed
Has Results
  • Advanced Cancer
  • +5 more
  • Boston, Massachusetts
  • +3 more
Nov 24, 2020

Gastroesophageal Junction Adenocarcinoma, Esophagogastric Cancer Trial in Boston, Newton (FOLFOX/ nal-IRI, Paclitaxel,

Not yet recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • Esophagogastric Cancer
  • FOLFOX/ nal-IRI
  • +3 more
  • Boston, Massachusetts
  • +2 more
Nov 30, 2020

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Seoul (Ramucirumab, Paclitaxel)

Completed
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 17, 2020

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Andecaliximab, Nivolumab)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Los Angeles, California
  • +33 more
Sep 17, 2020

Solid Tumor, Hepatocellular Carcinoma, Gastric Cancer Trial in Saint Louis (Vorolanib, Nivolumab, Pembrolizumab)

Terminated
  • Solid Tumor
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 27, 2020

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Tucson, Arizona
  • +44 more
Jun 26, 2020

Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III

Unknown status
  • Advanced Gastroesophageal Junction Adenocarcinoma
  • +24 more
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Jun 18, 2020

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab, Paclitaxel)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Duarte, California
  • +51 more
Jun 10, 2020

Locally Advanced Unresectable Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Metastatic

Withdrawn
  • Locally Advanced Unresectable Gastric Adenocarcinoma
  • +5 more
  • Liposomal Irinotecan
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Mar 25, 2020

Gastroesophageal Junction Adenocarcinoma Trial in Shijia Zhuang (Apatinib Capecitabine Oxaliplatin, Capecitabine Oxaliplatin)

Unknown status
  • Gastroesophageal Junction Adenocarcinoma
  • Apatinib Capecitabine Oxaliplatin
  • Capecitabine Oxaliplatin
  • Shijia Zhuang, Hebei, China
    QunZhao
Feb 18, 2020

Gastroesophageal Junction Adenocarcinoma Trial in ShiJiaZhuang (apatinib, Capecitabine, Oxaliplatin)

Unknown status
  • Gastroesophageal Junction Adenocarcinoma
  • ShiJiaZhuang, Hebei, China
    The Fourth Hospital of Hebei Medical University
Feb 18, 2020

Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Trastuzumab, Capecitabine, Oxaliplatin)

Unknown status
  • Gastroesophageal Junction Adenocarcinoma
  • Shijiazhuang, Hebei, China
    Fourth Affiliated Hospital of Hebei Medical University
Feb 18, 2020

Gastroesophageal Junction Adenocarcinoma, Stomach Adenocarcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma Trial in

Unknown status
  • Gastroesophageal Junction Adenocarcinoma
  • +3 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Feb 8, 2020

Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Trial in United States (Docetaxel, Leucovorin, Fluorouracil, Cisplatin,

Completed
Has Results
  • Gastroesophageal Junction Adenocarcinoma
  • Gastric Cancer
  • Docetaxel, Leucovorin, Fluorouracil, Cisplatin
  • +2 more
  • Duarte, California
  • +14 more
Nov 25, 2019

Gastroesophageal Junction Adenocarcinoma, Malignant Tumor of the Cervical Esophagus, Malignant Tumor of the Thoracic Esophagus

Completed
  • Gastroesophageal Junction Adenocarcinoma
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 22, 2019

NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Birmingham, Alabama
  • +10 more
Jul 17, 2019

Gastroesophageal Junction Adenocarcinoma, Adenocarcinoma of the Stomach Trial in Berlin (Avelumab, Ramucirumab, Paclitaxel)

Recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • Adenocarcinoma of the Stomach
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
May 30, 2019

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Pesaro (capecitabine, Docetaxel)

Unknown status
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Pesaro, Italy
  • +1 more
Feb 26, 2019

Gastric Adenocarcinoma, Advanced Solid Tumors, Gastroesophageal Junction Adenocarcinoma Trial in Beijing (AK104, Oxaliplatin,

Unknown status
  • Gastric Adenocarcinoma
  • +2 more
  • AK104
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Feb 22, 2019

Gastroesophageal Junction Adenocarcinoma, Surgery Trial in Copenhagen Ø

Completed
  • Gastroesophageal Junction Adenocarcinoma
  • Surgery
    • Copenhagen Ø, Denmark
      Department of Surgical Gastroenterology, Rigshospitalet
    May 3, 2015

    Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Spain (panitumumab + docetaxel + cisplatino)

    Unknown status
    • Gastric Adenocarcinoma
    • Gastroesophageal Junction Adenocarcinoma
    • panitumumab + docetaxel + cisplatino
    • Ferrol, La Coruña, Spain
    • +8 more
    Mar 10, 2015

    Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Georgia, United States

    Unknown status
    • Gastric Adenocarcinoma
    • +2 more
    • Dallas, Texas
    • +4 more
    Nov 28, 2014

    Gastric Junction Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Montreal (Taxotere, Cisplatin, and 5-FU)

    Unknown status
    • Gastric Junction Adenocarcinoma
    • Gastroesophageal Junction Adenocarcinoma
    • Taxotere, Cisplatin, and 5-FU
    • Montreal, Quebec, Canada
      McGill University
    Oct 20, 2008